A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02507102 |
|
Recruitment Status :
Completed
First Posted : July 23, 2015
Last Update Posted : March 30, 2018
|
Sponsor:
Nativis, Inc.
Information provided by (Responsible Party):
Nativis, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | December 2017 |
| Actual Study Completion Date : | March 26, 2018 |